| Literature DB >> 30208946 |
Hiroaki Yanagawa1, Rumi Katashima2, Chiho Sato2, Kenshi Takechi2, Hiroshi Nokihara2, Chikako Kane2, Masayuki Chuma2, Yuki Aoe2.
Abstract
OBJECTIVE: Research ethics consultation is an advisory activity that differs from ethics committees, and its role is not yet widely known in Japan. Research ethics consultations were started in 2012 by members of the Clinical Trial Center of Tokushima University Hospital, a support section for clinical trials. We analyzed the research ethics consultation records from Tokushima University Hospital during the 5-year period of 2012-2016 to examine the Japanese context of research ethics consultation.Entities:
Keywords: Clinical research; Japan; Regulation compatibility; Research ethics; Research ethics consultation
Mesh:
Year: 2018 PMID: 30208946 PMCID: PMC6134693 DOI: 10.1186/s13104-018-3772-0
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Annual numbers and timing of research ethics consultations at Tokushima University Hospital
| Before starting studies (%) | After starting studies (%) | Total | |
|---|---|---|---|
| 2012 | 34 (97%) | 1 (3%) | 35 |
| 2013 | 17 (89%) | 2 (11%) | 19 |
| 2014 | 24 (100%) | 0 (0%) | 24 |
| 2015 | 16 (84%) | 3 (16%) | 19 |
| 2016 | 24 (86%) | 4 (14%) | 28 |
| Total | 115 (91%) | 10 (9%) | 125 |
Issues of research ethics consultations in 5 years at Tokushima University Hospital
| Category | Issues | 2012 | 2013 | 2014 | 2015 | 2016 | Total (%) |
|---|---|---|---|---|---|---|---|
| A | Issues on research ethics that investigators face in their research | 2 | 0 | 0 | 0 | 4 | 6 (4.8%) |
| B | Compatibility with Japanese government guidelines | 20 | 7 | 14 | 14 | 12 | 67 (53.6%) |
| Compatibility with other guidance and regulations | 3 | 4 | 6 | 2 | 2 | 17 (13.6%) | |
| C | Application of ethics review (except documents themselves) | 7 | 6 | 4 | 2 | 8 | 27 (21.6%) |
| D | Others | 3 | 2 | 0 | 1 | 2 | 8 (6.4%) |
| Total | 35 | 19 | 24 | 19 | 28 | 125 |
Topics of research ethics consultations of compatibility with Japanese government guidelines and other guidance and regulations
| Topics | 2012 | 2013 | 2014 | 2015 | 2016 | Total (%) |
|---|---|---|---|---|---|---|
| Ethical handling of human biological specimens | 2 | 2 | 1 | 5 | 3 | 13 (15.5%) |
| Ethical handling of information utilized in research | 6 | 2 | 3 | 6 | 0 | 17 (20.1%) |
| Necessity and way of informed consent | 2 | 0 | 5 | 1 | 0 | 8 (9.5%) |
| Categorization of invasiveness | 0 | 0 | 0 | 1 | 1 | 2 (2.4%) |
| Categorization of intervention | 6 | 0 | 3 | 1 | 3 | 13 (15.5%) |
| Application of ethical guidelines | 4 | 3 | 2 | 0 | 5 | 14 (16.7%) |
| Examination of functions of food and supplements | 3 | 0 | 0 | 1 | 2 | 6 (7.1%) |
| Advanced medicine | 0 | 2 | 1 | 1 | 0 | 4 (4.8%) |
| Trials for governmental approval (registration trials) | 0 | 1 | 2 | 0 | 0 | 3 (3.6%) |
| Gene therapy | 0 | 1 | 0 | 0 | 0 | 1 (1.2%) |
| Regenerative medicine | 0 | 0 | 1 | 0 | 0 | 1 (1.2%) |
| Good clinical practice | 0 | 0 | 1 | 0 | 0 | 1 (1.2%) |
| Insurance in clinical trials | 0 | 0 | 1 | 0 | 0 | 1 (1.2%) |
| Total | 23 | 11 | 20 | 16 | 14 | 84 |